Jeff Bezos and Sovereign AI back CuspAI in $450M raise
Summary
CuspAI, a UK startup using AI to discover new materials for clean energy and chipmaking, raised $450M in Series B funding led by Kleiner Perkins and NEA, with participation from Jeff Bezos and the UK's Sovereign AI Fund.
View Cached Full Text
Cached at: 07/21/26, 06:49 AM
Similar Articles
AI Startup Cognition Set to Raise Around $1 Billion at a $47 Billion Value (2 minute read)
Cognition, an AI startup, is set to raise around $1 billion in funding at a $47 billion valuation, with annualized revenue exceeding $900 million.
Scaling AI for everyone
OpenAI announces $110B in new investment at a $730B pre-money valuation, including major funding from SoftBank, NVIDIA, and Amazon, along with strategic partnerships to expand compute capacity and global reach for AI products. The funding aims to accelerate deployment of frontier AI across consumers, developers, and enterprises worldwide.
General Catalyst leads $1.1B round into 2-month-old River AI
River AI, founded by xAI co-founder Igor Babuschkin, raised $1.1B in seed/Series A funding led by General Catalyst, with participation from Nvidia, AMD Ventures, Y Combinator, and Temasek. The startup aims to rebuild the AI stack from scratch to enable personally trainable AI agents, and offers an API for RL and LoRA fine-tuning on open models.
Jeff Bezos Is Funding a Wild Hunt for the Brain’s ‘Core Algorithm’
Jeff Bezos has funded Flourish, a neuro-AI startup valued at $2.5 billion with $500 million in funding, co-founded by former Amazon executive Rob Williams and neuroscientist Thomas Reardon. The company aims to build brain-inspired AI systems called Cortex AI that can run on 50 watts or less and continuously learn, addressing key limitations of current LLMs.
@odysseyml: We’ve raised a $310M Series B to accelerate world models! We believe AI that can understand and simulate the world will…
OdysseyML announces a $310M Series B funding round to advance world models, with backing from Natural Capital, Amazon, GV, AMD, and IQT.